Nov 08, 2017 14:12 pm UTC| Business
Waltham, MA, Nov. 08, 2017 -- CallMiner, the leader in speech and customer engagement analytics, held its ninth annual LISTEN 2017 conference, October 25-27. During the event, LISTEN awards were presented to analysts...
Nov 08, 2017 14:11 pm UTC| Business
Albany, New York, Nov. 08, 2017 -- The global food additives market is fragmented with large number of players such as Archer Daniels Midland Company (U.S.), E.I. DuPont (U.S.), Cargill, Incorporated (U.S.), Kerry Group...
Nov 08, 2017 14:08 pm UTC| Business
PHOENIX, Nov. 08, 2017 -- The CEO of Lithium Exploration Group Inc. (USOTC:LEXG) believes that the recent unrest in Saudi Arabia, the leading OPEC producer, will finally unlock the price increase that the oil market has...
Nov 08, 2017 14:05 pm UTC| Business
ARLINGTON, Va., Nov. 08, 2017 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, today announced a strategic alliance with e2Value®, a provider of web-based property...
Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results
Nov 08, 2017 14:05 pm UTC| Business
VANCOUVER, British Columbia, Nov. 08, 2017 -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of...
On Fly Green Day, Eight Airlines Fly with Gevo’s Jet Fuel from O’Hare
Nov 08, 2017 14:02 pm UTC| Business
ENGLEWOOD, Colo., Nov. 08, 2017 -- Gevo, Inc. (NASDAQ:GEVO), announced today that its alcohol-to-jet fuel (ATJ) derived from renewable isobutanol is being used today by eight commercial airlines for Fly Green Day,...
May the Best Friend Win! Zynga Launches Words With Friends 2 to Global Audiences
Nov 08, 2017 14:02 pm UTC| Business
SAN FRANCISCO, Nov. 08, 2017 -- Today, Zynga (Nasdaq:ZNGA), a leading social game developer, announced the launch of Words With Friends 2, a next-generation take on the world’s most popular mobile word game. With...
FxWirePro- Major economic events for the week
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update